drugset / Trial / NCT04191460

Fluorescence-guided Surgery Using cRGD-ZW800-1 in Oral Cancer

NCT04191460 ↗

Phase 2 Recruiting 28 enrolled Erasmus Medical Center
Non-randomizedSequentialOpen-labelDiagnostic

Summary

This is a two-staged clinical trial to investigate the feasibility of intraoperative Fluorescence Imaging (FLI) to adequately assess tumor margins in patients with oral cancer using cRGD-ZW800-1.

Timeline

Start
2022-07-12
Primary completion
2025-05-01
Completion
2025-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject cRGD-ZW800-1 Diagnostic / imaging agent 0.05 mg/kg Other